We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Introduction

Transfer of knowledge and technology to the industrial sector is an integral part of the institute’s activities. During 2013, the technology development unit CSOL has been involved in several collaborative projects with industry in the field of homogeneous catalysis as well as performing valorization projects to develop the inventions made by ICIQ’s research groups into technologies that are ready to be transferred to the industry.

As for Crysforma, it continues expanding its capabilities in the field of pharmaceutical solid state development by organizing providing new analytical services using the X-ray beam line at the ALBA synchrotron.Moreover, Crysforma organized its 3rd workshop on solid state development oriented towards industry professionals.

Globally, 15 research projects with industry have been active during 2013, including the Esteve-ICIQ and Henkel-ICIQ joint units. Finally,4 patents have been applied for, arising from the research results from ICIQ’s groups.